Ghent University Academic Bibliography

Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma

Arthur Bobin, Maeva Kyheng, Stephanie Guidez, Cecile Gruchet-Merouze, Valentine Richez, Alain Duhamel, Lionel Karlin, Brigitte Kolb, Mourad Tiab, Carla Araujo, et al.

(2022) LEUKEMIA. 36(3). p.881-884

Add to list

Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination

Valeria Tosello, Deborah Bongiovanni, Jingjing Liu, Qingfei Pan, Koon-kiu Yan, Valentina Saccomani, Maaike Van Trimpont (UGent) , Marco Pizzi, Martina Mazzoni, Angelo Paolo Dei Tos, et al.

(2021) LEUKEMIA. 35(4). p.984-1000

Add to list

PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis

E. G. Garcia, A. Veloso, M. L. Oliveira, J. R. Allen, S. Loontiens, D. Brunson, D. Do, C. Yan, R. Morris, S. Iyer, et al.

(2021) LEUKEMIA. 35. p.679-690

Add to list

T-ALL can evolve to oncogene independence

Hesham Abdulla, Anh Vo, Benjamin J. Shields, Tenae J. Davies, Jacob T. Jackson, Raed Alserihi, Elizabeth M. Viney, Tin Wong, Feng Yan, Nicholas C. Wong, et al.

(2021) LEUKEMIA. 35(8). p.2205-2219

Add to list

Journal Article
A1
open access

Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

Judith M. Boer, Maria Grazia Valsecchi, Femke M. Hormann, Željko Antić, Marketa Zaliova, Claire Schwab, Giovanni Cazzaniga, Chloé Arfeuille, Hélène Cavé, Andishe Attarbaschi, et al.

(2021) LEUKEMIA. 35(10). p.2978-2982

Add to list

Journal Article
A1
open access

Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies

Melanie Decker, Tim Lammens (UGent) , Alina Ferster, Miriam Erlacher, Ayami Yoshimi, Charlotte M. Niemeyer, Martijn P. T. Ernst, Marc H. G. P. Raaijmakers, Nicolas Duployez, Andreas Flaum, et al.

(2021) LEUKEMIA. 35(11). p.3304-3308

Add to list

Journal Article
A1
open access

Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency

Emilia J. Kozyra, Victor B. Pastor, Stylianos Lefkopoulos, Sushree S. Sahoo, Hauke Busch, Rebecca K. Voss, Miriam Erlacher, Dirk Lebrecht, Enikoe A. Szvetnik, Shinsuke Hirabayashi, et al.

(2020) LEUKEMIA. 34(10). p.2673-2687

Add to list

A novel TLX1-driven T-ALL zebrafish model : comparative genomic analysis with other leukemia models

Siebe Loontiens (UGent) , Suzanne Vanhauwaert (UGent) , Lisa Depestel (UGent) , Givani Dewyn (UGent) , Wouter Van Loocke (UGent) , Finola E. Moore, Elaine G. Garcia, Lance Batchelor, Chiara Borga, Barbara Squiban, et al.

(2020) LEUKEMIA. 34(12). p.3398-3403

Add to list

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

G. J. Ossenkoppele, D. A. Breems, G. Stuessi, Y. Van Norden, M. Bargetzi, B. J. Biemond, P. A von dem Borne, Y. Chalandon, J. Cloos, D. Deeren, et al.

(2020) LEUKEMIA. 34(7). p.1751-1759

Add to list

Journal Article
A1
open access

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL : 5 years of follow-up from the phase 3 RESONATE-2 study

Jan A. Burger, Paul M. Barr, Tadeusz Robak, Carolyn Owen, Paolo Ghia, Alessandra Tedeschi, Osnat Bairey, Peter Hillmen, Steven E. Coutre, Stephen Devereux, et al.

(2020) LEUKEMIA. 34(3). p.787-798

Academic Bibliography

Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma

Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination

PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis

T-ALL can evolve to oncogene independence

Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies

Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency

A novel TLX1-driven T-ALL zebrafish model : comparative genomic analysis with other leukemia models

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL : 5 years of follow-up from the phase 3 RESONATE-2 study

Contents

Support

Contact